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Abstract : Raman spectroscopy has become a remarkable tool for real-time detection 
and diagnosis of various cancers.  We investigated whether Raman spectroscopy can 
be used to diagnose colorectal cancer.  Samples of cancerous and non-cancerous 
tissues were obtained from 12 patients undergoing surgery for such cancer.  A 
handheld Raman spectrometer employing an excitation wavelength of 1,064 nm 
was used at 94 points : 48 points on cancerous tissues and 46 points on normal 
tissues.  Using principal component analysis （PCA）, we selected 12 PCs from the 
Raman spectra obtained at each of the 94 observed points.  We then used linear 
discriminant analysis （LDA） to distinguish cancer from normal tissues and early 
cancer from advanced cancer, and we calculated sensitivity, specicity, and accuracy 
of the Raman spectroscopy for such diagnoses.  We immediately conrmed that 
there was no local temperature rise, color change, or damage at the irradiated 
points, and we found that Raman spectroscopy was able to distinguish cancer from 
normal tissues with a sensitivity of 87.5％, specificity of 82.6％, and accuracy of 
85.1％.  In addition, Raman spectroscopy distinguished early cancer from advanced 
cancer with a sensitivity of 85.7％, specificity of 83.3％, and accuracy of 85.4％.  
Thus, near-infrared Raman spectroscopy shows potential as an objective, rapid, non-
invasive diagnostic modality for colorectal cancer.
Key words : colorectal cancer, Raman spectroscopy, handheld spectrometer, 1,064-nm 
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Introduction
　Colorectal cancer is one of the most common cancers worldwide and, in 2016, it was the 
second most common cause of death from cancer in Japan 1）.  Five-year survival is 96.6％ for 
patients with localized colorectal cancer, 72.1％ for those with lymph node metastasis, and 15.8％ 
for those with distant metastasis 2）.  Thus, early diagnosis and treatment greatly influence the 
prognosis.  Currently, pathological analysis of biopsy specimens is regarded as the standard proce-
dure for denitive diagnosis and staging of colorectal cancer ; however, pathological examination 
is both time-consuming and costly.
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　Raman spectroscopy is emerging as an important tool for real-time detection and diagnosis 
of various cancers.  First described by C.V. Raman in 1928, Raman spectroscopy is an imaging 
technique based on inelastic scattering of monochromatic light from a laser, whereby photon 
frequencies change upon interaction with a sample 3–5）.  When a molecule is excited by the 
photon, the frequency of the re-emitted photon shifts up or down relative to the original mono-
chromatic frequency.  This phenomenon is called the Raman shift （or Raman effect）.  The shift 
in frequency provides unique information on molecules 6, 7） that allows for tissue ngerprinting 
by characterizing the protein, DNA, and lipid content of cells.  Thus far, clinical application of 
Raman spectroscopy has been difcult due to masking of the relatively weak Raman scattering 
by the strong fluorescence emitted by biological tissue.  Indeed, some human tissue samples 
emit fluorescence even when excited at 800 nm 8, 9）.  Long-wavelength, near-infrared light has 
been shown to prevent interference by uorescence 10）.  Additionally, use of near-infrared light 
is advantageous for spectroscopic characterization and analysis of biological tissues because the 
samples are not damaged by the laser beam-generated heat 11）.  We therefore investigated whether 
Raman spectroscopy, performed with a handheld spectrometer, has the potential for practical, 
objective, rapid diagnosis of surgically resected colorectal cancer.
Materials and methods
Tissue samples
　The specimens of adenocarcinoma and adjacent normal tissues analyzed in this study came 
from 12 patients undergoing surgical resection for pathologically diagnosed colorectal cancer at 
the Department of Gastroenterological and General Surgery, Showa University Fujigaoka 
Hospital, from October 2016 to March 2017.  The excised tissues were cut into 1-cm square 
blocks, wrapped in plastic, and stored up to one hour before examination.
　Patient and tumor characteristics are summarized in Table 1.  Located in the ascending colon 
（n＝3, 25.0％）, transverse colon （n＝1, 8.3％）, sigmoid colon （n＝2, 16.7％）, or rectum （n＝6, 
50.0％）, the cancerous tissues were classied histologically as well-differentiated （n＝6, 50％） or 
moderately differentiated adenocarcinoma （n＝6, 50％）, and morphologically as type 0 （n＝2, 
16.7％）, type 2 （n＝7, 58.3％）, type 3 （n＝2, 16.7％）, type 4 （n＝0, 0.0％）, or type 5 （n＝1, 
8.3％）; there were no type 1 tumors.  Two of the cancers （16.7％） were early cancers （sub-
mucosal invasion）, and 10 （83.3％） were advanced cancers （muscularis propria invasion ［n＝1］, 
subserosal penetration ［n＝5］, and serosal penetration ［n＝4］）.  Tumor stages according to the 
UICC （International Union Against Cancer） were as follows : stage Ⅰ （n＝2, 16.7％）, stage 
ⅡA （n＝2, 16.7％）, stage ⅡB （n＝1, 8.3％）, stage ⅢA （n＝1, 8.3％）, stage ⅢB （n＝3, 25.0％）, 
stage ⅣA （n＝2, 16.7％）, and stage ⅣB （n＝1, 8.3％）.
Ethics statement
　The Institutional Review Board of Fujigaoka Hospital approved the study protocol （permission 
number : 2016012）.  All 12 patients were informed of the study and provided written consent for 
scientic use of the surgical specimens.
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Handheld Raman spectrometer
　We used an easy-to-handle ProgenyTM spectrometer （Rigaku Raman Technologies Inc., Tokyo, 
Japan）12, 13）, measuring 29.9×8.0×7.4 cm, weighing 1.6 kg, and equipped with a thermoelectrically 
cooled InGaAs detector that is highly sensitive to near-infrared light.  Radiation can be 
measured correctly, even through vinyl, by adjustment of the focal length in increments of 
0.5 mm.  The ProgenyTM spectrometer overcomes the interference of sample-induced uorescence 
by virtue of a unique 1,064-nm excitation laser for expanded positive material identication.
Irradiation and Raman spectra measurement
　Spectroscopic analysis of the tissue samples was performed at room temperature.  Raman 
spectra of the colorectal cancer tissues （1-3 blocks per patient） and adjacent normal tissues （1-3 
blocks per patient） were generated with a 1,064-nm excitation laser （Fig. 1a）.  The tissue was 
Table 1.  Patients and Tumor Characteristics
Patient
Age 
（years） Sex
Tumor 
location
Histological 
type
Morphological 
type
T N M Stage
Tumor 
progression
1 76 M T tub1 2 3 1a 0 ⅢB Advanced
2 56 M S tub2 3 4a X 1b ⅣB Advanced
3 69 M RS tub2 2 3 0 0 ⅡA Advanced
4 81 F Ra tub1 0-Ⅱa 1 0 0 I Early
5 73 M RS tub2 5 3 1b 0 ⅢB Advanced
6 73 M RS tub1 2 4a 0 0 ⅡB Advanced
7 73 M A tub1 2 3 0 0 ⅡA Advanced
8 74 F A tub2 0-Ⅱa 1 0 0 Ⅰ Early
9 76 M A tub1 2 4a 1b 0 ⅢB Advanced
10 67 M Rb tub2 2 2 1b 0 ⅢA Advanced
11 81 M S tub1 3 3 2a 1a ⅣA Advanced
12 68 M RS tub2 2 4a 1a 1a ⅣA Advanced
A : ascending colon, T : transverse colon, S : sigmoid colon, RS : rectosigmoid
Ra : rectum above peritoneal reection, Rb : rectum below peritoneal reection
tub1 : well differentiated adenocarcinoma, tub2 : moderately differentiated adenocarcinoma
Fig. 1.  （a） The handheld Raman spectrometer, ProgenyTM （Rigaku Raman Technologies 
Inc.） equipped with a 1,064-nm laser, （b） The handheld Raman spectrometer in use.
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irradiated on the mucosal side through the plastic wrap （Fig. 1b）, with each block irradiated at 
3-5 spots randomly and checked for any laser damage.  The settings were as follows : average 
power, 490 mW ; exposure time, 5,000 ms ; averaging frequency, 30 count.  The InGaAs detector 
allowed both measurement of Raman scattering and analysis of Raman spectra, the latter of 
which were expressed in wavenumbers ranging from 800 cm-1 to 1,800 cm-1.  Comparisons were 
then made between the spectra of the cancer tissues and those of the normal tissues.
Statistical analysis
　Spectral data were processed and analyzed statistically by means of SYSTAT ver. 13 （Systat 
Software Inc., San Jose, CA, USA）.  We used principal component analysis （PCA） to identify 
and extract the major trends within a given spectral data set.  PCA produces principal compo-
nents （PCs） to concentrate all spectral information with minimal information loss 14）.  The rst 
PC accounts for the maximum amount of variance present in the spectral data set, whereas 
successive PCs account for features contributing to progressively smaller variances.  We selected 
12 PCs from the Raman spectra collected at each of the 94 observed points （Fig. 2）.  No single 
PC or combination of PCs could efciently distinguish cancer tissues and normal tissues.  There-
fore, we used all 12 PCs to nd the best discriminating components.  This is in keeping with 
Kawabata et al 15）, who used all the PCs （10 in their case） to develop a Raman spectroscopy-
based system for ex vivo diagnosis of gastric cancer.  As a second step, the 12 PC were entered 
Fig. 2.  The 12 principal components （PCs） obtained from analysis of the 94 Raman spectra
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into a linear discriminant analysis （LDA）, to distinguish cancer tissues from normal tissues and 
early cancer from advanced cancer.  We calculated the sensitivity, specificity, and accuracy of 
Raman spectroscopy for such diagnoses.
Results
Investigation of Raman spectra
　Across the 24 irradiated tissues, we detected no local temperature rise, color change, or 
damage at any of the 94 points.  The general pattern similarity amongst all 94 Raman spectra 
obtained from the cancerous and normal tissue specimens is shown in Figure 3a, with the 
average spectra for both tissue types shown in Figure 3b.  For each spectra, typical Raman 
peaks were identied at 1,658 cm-1, 1,447 cm-1, and 1,271 cm-1, which correspond to the protein 
amide Ⅰ band, the CH2 bending, and the protein amide Ⅲ band, respectively.  As depicted 
in Figure 3c, the spectral differences （cancerous tissue spectra minus normal tissue spectra） 
revealed higher intensities for the cancer tissues in comparison to the normal tissues, especially 
at 1,663 cm-1 and 1,332 cm-1 ; however, at 1,442 cm-1 the spectral intensities of the cancer tissues 
were lower than those of normal tissues.
Fig. 3.  （a） The total of 94 Raman spectra of cancer tissues and normal tissues, （b） Average Raman spectra of 
cancer tissues and normal tissues, （c） Differences in spectra （cancer tissues minus normal tissues）.
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PCA and LDA
　PCA was used for all 94 Raman spectra to detect diagnostically important spectral differences. 
The 12 PCs obtained from the 94 Raman spectra （PC1-12） are shown in Figure 2.  When all 
12 PCs were analyzed using LDA, 42 of the 48 spectra from cancer tissues and 38 of the 46 
spectra from normal tissues were accurately classified （Table 2）, with a sensitivity of 87.5％, 
specicity of 82.6％, and accuracy of 85.1％.  We also examined whether Raman spectroscopy 
could distinguish early cancer （T1） from advanced cancer （T2–T4） using the 48 cancerous tissue 
spectra.  Then again using PCA and LDA, we determined that 5 of 6 spectra from the early 
cancers and 36 of 42 spectra from the advanced cancers were accurately classied （Table 3）, 
with a sensitivity of 85.7％, specicity of 83.3％, and accuracy of 85.4％.
Discussion
　Raman spectroscopy was rst used in the eld of chemistry and then later developed as a 
scientic tool for examining pathological tissues.  The advantage of Raman spectroscopy is that 
it can be used to provide rapid, noninvasive detection.  Raman spectroscopy has been used 
in the detection of various cancers including gastrointestinal 15–18）, breast 19）, lung 10, 20）, uterine 21）, 
nasopharyngeal 22）, laryngeal 23）, and skin 24） cancers.  Peak positions and vibrational modes already 
assigned are shown in Table 4.  In gastrointestinal tissue, the differences in Raman spectra have 
been recognized mainly at 1,655 / 59 cm-1, 1,450 / 3 cm-1, 1,310 cm-1, 1,260 cm-1, and 1,003 cm-1 25）. 
In our colorectal tissue samples, Raman peaks were typically identied at 1,658 cm-1 （protein 
Table 4.  Peak position and vibrational mode assignment
Peak position （cm-1） Vibrational mode Major assignments
≈ 1,000 Symmetric ring breathing Phenylalanine
1,240-1,280 Amide Ⅲ （C-N stretching） Proteins （α-helix）, lipids
1,300-1,315 CH3CH2 twisting Nucleic acids, collagen, lipids
≈ 1,335 CH3CH2 wagging Nucleic acids, collagen
≈ 1,450 CH2 bending Lipids, proteins
1,650-1,665 Amide Ⅰ （C＝O stretching） Proteins （α-helix）, lipids
Table 2.  Discrimination analysis of cancer and 
normal tissue
Pathological diagnosis
（n＝94） Cancer Normal
Raman 
classification
Cancer 42 8
Normal 6 38
Total 48 46
 Sensitivity 87.5％, Specicity 82.6％, Accuracy 85.1％
Table 3.  Discrimination analysis of advanced and early 
cancer
Pathological diagnosis
（n＝48）
Advanced 
cancer
Early 
cancer
Raman 
classification
Advanced cancer 36 1
Early cancer 6 5
Total 42 6
 Sensitivity 85.7％, Specicity 83.3％, Accuracy 85.4％
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amide Ⅰ）, 1,447 cm-1 （CH2 bending）, and 1,271 cm-1 （protein amide Ⅲ）, indicating that ProgenyTM 
was able to measure Raman spectra precisely despite the emission of fluorescence from the 
irradiated tissues.
　Min et al 10） reported that when lung cancer develops, the increased amount of protein makes 
the tissues dense, and it is the most likely cause of the increased amide Ⅰ band intensity in 
cancer tissues.  Furthermore, Feld et al 26） reported intense nucleic acid vibrational modes in 
adenocarcinoma, indicative of a higher nucleic acid content in the samples.  In our study, the 
difference in spectra （cancer minus normal） was great at amide Ⅰ （mainly protein） and in 
association with CH3CH2 wagging （mainly nucleic acid）, supporting greater amounts of protein 
and nucleic acid in cancer tissues than in normal tissues.  Feld et al 26） also reported more 
intense signals from lipids in their samples of normal tissue.  The small difference in spectra 
（cancer minus normal） that we observed in association with CH2 bending （lipid） is in agree-
ment with their ndings.
　To detect statistically significant differences in spectra between cancer tissues and normal 
tissues, we used PCA and LDA, which are multivariate analysis techniques used in many inves-
tigations of Raman spectroscopy-based cancer diagnosis 14, 15, 17, 22, 23）.  Our PCA and LDA results 
were consistent with the results of these previously reported studies in that Raman spectroscopy 
successfully and accurately discriminated between cancer tissues and normal tissues.  In addition, 
we found that Raman spectroscopy could discriminate with high accuracy between early cancer 
and advanced cancer.  In comparison to visible light, near-infrared light can penetrate more 
deeply into tissue, making Raman spectroscopy well suited to minimizing tissue uorescence 7）. 
Thus, Raman spectroscopy may become useful for evaluating the depth of tumor invasion.
　Raman spectroscopy is especially suitable for in vivo assessment because the excitation light, 
regardless of its power, does not affect the tissue 4）.  We conrmed in our study that the tissues 
irradiated by Raman spectroscopy were not damaged, and thus we speculate that the 1,064-nm 
laser can be used safely in vivo, although further studies must be carried out to ensure that 
Raman scanning will not damage DNA in normal tissues.
　In the study described herein, we focused on practical clinical applicability by using a 
handheld Raman spectrometer.  Indeed, the portability of ProgenyTM is often exploited in the 
aftermath of disasters.  Miniaturizing a device often compromises its accuracy and performance, 
and thus large spectrometers are most often used for cancer detection.  However, we were 
able to diagnose colorectal cancer with a handheld Raman spectrometer equipped with a high 
performance detector.  Technological innovation has allowed for reduction in the size of Raman 
spectrometers, and investigators have recently reported using endoscopic Raman spectroscopy 
probes for real-time diagnosis and assistance in determining an adequate surgical margin during 
endoscopic resection 27, 28）.  We anticipate that further development of intraoperative devices will 
aid in determining the excision line or extent of lymph node dissection when intraoperative 
assessment of colorectal tissues from the serosa side, lymph nodes, and nearby organs and 
structures （e.g., uterus, prostate, ureter, and blood vessels） is needed.
　In conclusion, we investigated whether near-infrared Raman spectroscopy performed with a 
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handheld spectrometer with 1,064-nm excitation can be applied clinically for the diagnosis of 
colorectal cancer, and we obtained favorable results.  We anticipate that similar applications of 
Raman spectroscopy will become increasingly important for both rapid and objective assessments 
of cancer and non-invasive procedures.
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